赛伦生物
(688163)
| 流通市值：7.65亿 | | | 总市值：18.65亿 |
| 流通股本：4437.20万 | | | 总股本：1.08亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 210,364,165.68 | 172,338,491.66 | 124,093,875.96 | 150,921,948.01 |
| 应收票据及应收账款 | 57,985,723.41 | 59,478,712.91 | 38,499,090.2 | 22,634,950.22 |
| 应收账款 | 57,985,723.41 | 59,478,712.91 | 38,499,090.2 | 22,634,950.22 |
| 预付款项 | 11,786,087.54 | 1,523,638.04 | 1,109,076.07 | 1,489,329.52 |
| 其他应收款合计 | 1,773,988.6 | 520,060.34 | 1,110,999.94 | 712,416.7 |
| 存货 | 36,749,332.97 | 42,851,453.79 | 47,437,803.13 | 44,748,509.91 |
| 其他流动资产 | 7,977,277.67 | 9,566,963.32 | 5,844,519.13 | 5,832,375.59 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 968,139,753.95 | 938,254,270.74 | 940,355,041.14 | 948,930,376.53 |
| 非流动资产: | | | | |
| 长期股权投资 | 14,289,991.57 | 14,898,390.99 | 15,603,515.97 | 16,593,941.81 |
| 固定资产 | 104,210,591.51 | 106,330,638.64 | 57,192,757.72 | 58,351,109.28 |
| 在建工程 | 17,358,536.87 | 8,763,327.63 | 59,655,542.87 | 54,604,190.26 |
| 生产性生物资产 | 3,945,275.91 | 4,399,941.39 | 4,579,325.35 | 3,460,677.25 |
| 使用权资产 | 3,710,941.96 | 10,951,187.19 | 11,179,336.92 | 11,407,486.65 |
| 无形资产 | 23,221,485.02 | 23,410,874.27 | 23,600,263.52 | 23,789,652.77 |
| 长期待摊费用 | 694,637.85 | 754,624.59 | 814,611.33 | 874,598.07 |
| 递延所得税资产 | 9,890,783.74 | 9,666,806.25 | 9,962,731.57 | 9,909,713.01 |
| 其他非流动资产 | 22,500 | 14,204,800 | 22,500 | 550,800 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 177,344,744.43 | 193,380,590.95 | 182,610,585.25 | 179,542,169.1 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 1,145,484,498.38 | 1,131,634,861.69 | 1,122,965,626.39 | 1,128,472,545.63 |
| 流动负债: | | | | |
| 应付票据及应付账款 | 2,017,615.13 | 2,245,376.04 | 3,398,481.68 | 3,635,753.93 |
| 应付账款 | 2,017,615.13 | 2,245,376.04 | 3,398,481.68 | 3,635,753.93 |
| 合同负债 | 2,394,955.64 | 1,813,206.3 | 2,642,029.4 | 2,926,660.83 |
| 应付职工薪酬 | 4,109,467.84 | 4,871,977.19 | 1,935,091.96 | 7,686,022.26 |
| 应交税费 | 6,174,998.94 | 2,513,102.38 | 1,475,097.24 | 460,639.9 |
| 其他应付款合计 | 6,743,457.16 | 5,716,769.77 | 7,541,349.2 | 9,431,873.61 |
| 应付股利 | 19,700 | 18,500 | 16,500 | 16,500 |
| 一年内到期的非流动负债 | 287,817.84 | 775,862.55 | 758,429.43 | 758,429.43 |
| 其他流动负债 | 71,848.67 | 54,396.19 | 97,794.22 | 86,392.72 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 21,800,161.22 | 17,990,690.42 | 17,848,273.13 | 24,985,772.68 |
| 非流动负债: | | | | |
| 租赁负债 | 4,194,713.95 | 11,807,876.55 | 12,356,008.9 | 12,200,215.63 |
| 递延所得税负债 | 5,331,876.99 | 5,331,876.99 | 5,445,951.85 | 5,445,951.85 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 9,526,590.94 | 17,139,753.54 | 17,801,960.75 | 17,646,167.48 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 31,326,752.16 | 35,130,443.96 | 35,650,233.88 | 42,631,940.16 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 108,220,000 | 108,220,000 | 108,220,000 | 108,220,000 |
| 资本公积 | 878,087,814.86 | 878,087,814.86 | 878,087,814.86 | 878,087,814.86 |
| 盈余公积 | 45,817,944.54 | 45,817,944.54 | 45,817,944.54 | 45,817,944.54 |
| 未分配利润 | 82,031,986.82 | 64,378,658.33 | 55,189,633.11 | 53,714,846.07 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,114,157,746.22 | 1,096,504,417.73 | 1,087,315,392.51 | 1,085,840,605.47 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,114,157,746.22 | 1,096,504,417.73 | 1,087,315,392.51 | 1,085,840,605.47 |
| 负债和股东权益合计 | 1,145,484,498.38 | 1,131,634,861.69 | 1,122,965,626.39 | 1,128,472,545.63 |
| 公告日期 | 2024-10-26 | 2024-08-28 | 2024-04-27 | 2024-04-27 |
| 审计意见(境内) | | | | 标准无保留意见 |